Go to:
Logótipo
Você está em: Start > Publications > View > Modulation of the myocardial effects of selective ETB receptor stimulation and its implications for heart failure [Modulação dos efeitos miocárdicos da estimulação selectiva dos receptores ETB e suas implicações na insuficiência cardíaca]
Map of Premises
Principal
Publication

Modulation of the myocardial effects of selective ETB receptor stimulation and its implications for heart failure [Modulação dos efeitos miocárdicos da estimulação selectiva dos receptores ETB e suas implicações na insuficiência cardíaca]

Title
Modulation of the myocardial effects of selective ETB receptor stimulation and its implications for heart failure [Modulação dos efeitos miocárdicos da estimulação selectiva dos receptores ETB e suas implicações na insuficiência cardíaca]
Type
Article in International Scientific Journal
Year
2005
Authors
Bras Silva, C
(Author)
FCNAUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Leite Moreira, AF
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Journal
Vol. 24 No. 11
Pages: 1125-1133
ISSN: 0870-2551
Indexing
Publicação em ISI Web of Knowledge ISI Web of Knowledge
Other information
Authenticus ID: P-007-ECY
Abstract (EN): Introduction: Endothelin-1 (ET-1) acts on two types of receptors, ET A and ETB. Recent functional studies suggest the existence of two ETB receptor subtypes in the heart: ETB1, located on endocardial endothelial cells and responsible for negative inotropisin, and ETB2, located on myocardial cells and responsible for positive inotropism. The aim of the present study was to investigate the mechanisms underlying the myocardial effects of selective ETB receptor stimulation. Methods: The study was performed on right papillary muscles from New Zealand white rabbits (n = 39; Krebs-Ringer; 1.8 mM CaCL2; 35°C). The effects of sarafotoxin S6c (SRTXc, ETB agonist; 0.2¿ M) were evaluated in muscles with: (i) intact endocardial endothelium (EE) (n = 6); (ii) damaged EE (Triton X100; 0.5%; n = 6); (iii) intact EE, in the presence of NG-nitro-L-arginine (L-NNA, nitric oxide synthase inhibitor; n = 6); (iv) intact EE, in the presence of indomethacin (INDO, cyclooxygenase inhibitor; n = 6); (v) intact EE, in the presence of BQ-123 (ETA antagonist; n = 7); and (vi) damaged EE, in the presence of BQ-123 (n = 8). Only significant results (mean ± SEM, p < 0.05) are given, expressed as % change from baseline. Results: In muscles with intact EE, SRTXc alone induced negative inotropic and lusitropic effects, decreasing active tension (AT) by 11.0 ± 5.6%, maximum velocity of tension rise (dT/dtmax) by 11.2 ± 5.9% and maximum velocity of tension decline (dT/dtmin) by 11.5 ± 6.2%. However, after removal of EE, or in the presence of L-NNA or INDO, SRTXc increased AT by 35.2 ± 11.7%, 22.8 ± 2.9% and 15.2 ± 3.4%, dT/dtmax by 29.5 ± 7.9%, 20.1 ± 2.1% and 13.3 ± 5.0%, and dT/dt min by 28.2 ± 8.1%, 21.2 ± 3.8% and 12.3 ± 2.2%, respectively. In muscles with intact EE and in the presence of BQ-123, the negative inotropic and lusitropic effects of SRTXc were enhanced: AT decreased by 27.0 ± 7.4%, dT/dtmax by 13.3 ± 4.9% and dT/dt min by 31.1 ± 7.9%. On the other hand, the positive inotropic and lusitropic effects of SRTXc in the absence of intact EE were reversed in the presence of ETA blockade: AT decreased by 9.0 ± 1.8%, dT/dtmax by 4.1 ± 3.5% and dT/dtmin by 8.1 ± 3.6%. Conclusions: The present study shows that the inotropic and lusilropic effects mediated by ETB receptors are modulated by endocardial endothelium and by ETA receptor activity. These results may have pathophysiological and therapeutic implications in heart failure, a condition in which ET-1 levels are increased and endothelial dysfunction may be present.
Language: English
Type (Professor's evaluation): Scientific
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same authors

Urocortin-2 improves right ventricular function in pulmonary arterial hypertension (2015)
Other Publications
Santos Ribeiro, D; Mendes Ferreira, P; Adao, R; Maia Rocha, C; Alves, BS; Rademaker, M; Leite Moreira, AF; Brás-Silva C
Urocortin-2 improves right ventricular function and attenuates experimental pulmonary arterial hypertension (2016)
Other Publications
Adao, R; Mendes Ferreira, P; Maia Rocha, C; Santos Ribeiro, D; Potus, F; Breuils Bonnet, S; Provencher, S; Bonnet, S; Rademaker, M; Leite Moreira, AF; Brás-Silva C
Urocortin-2 attenuates right ventricular dysfunction in pulmonary arterial hypertension (2016)
Other Publications
Adao, RR; Mendes Ferreira, P; Maia Rocha, C; Santos Ribeiro, D; Potus, F; Breuils Bonnet, S; Provencher, S; Bonnet, S; Leite Moreira, AF; Brás-Silva C
The urocortin 2-induced decrease in myocardial stiffness is compromised in heart failure (2008)
Other Publications
Brás-Silva C; Fontes Sousa, AP; Almeida, M; Mendes, S; Leite Moreira, AF

See all (18)

Of the same journal

The phenomenon of migration and cardiovascular risk factors (2018)
Another Publication in a National Scientific Journal
Campelo, M
Stabbed in the right place: The millimetric line between luck and disaster; [Apunhalado no sítio certo: a linha milimétrica entre a sorte e o desastre] (2023)
Another Publication in a National Scientific Journal
Amaral Marques, C; Mil Homens, F; Resende, CX; Fernandes, J; Gouveia, D; Pinho, P; Macedo, F
Social media use by cardiovascular healthcare professionals: Exploring a challenging and ever evolving frontier (2023)
Another Publication in a National Scientific Journal
Vilela, EM; José Pedro Nunes
Smoking in Portugal: Where do we stand today? (2019)
Another Publication in a National Scientific Journal
Pereira, AM
Sacubitril-valsartan in the real world: From theory to clinical practice (2018)
Another Publication in a National Scientific Journal
Fontes-Carvalho R

See all (628)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Medicina Dentária da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-08-30 at 06:55:19 | Privacy Policy | Personal Data Protection Policy | Whistleblowing | Electronic Yellow Book